Itraconazole and clarithromycin inhibit P-glycoprotein activity in primary human sinonasal epithelial cells.

about

Secreted P-glycoprotein is a noninvasive biomarker of chronic rhinosinusitis.Exosomes mediate interepithelial transfer of functional P-glycoprotein in chronic rhinosinusitis with nasal polyps.

P2860

Q38941714-802B4C3F-D191-44DA-ABEB-C7123F4D992A Q39293325-EED44C55-BE19-4A6D-9855-9FE6FB339CE0

P2860

Itraconazole and clarithromycin inhibit P-glycoprotein activity in primary human sinonasal epithelial cells.

Item

http://www.wikidata.org/entity/Q38439349

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Itraconazole and clarithromyci ...... an sinonasal epithelial cells.

@en

type

Item

label

Itraconazole and clarithromyci ...... an sinonasal epithelial cells.

@en

prefLabel

Itraconazole and clarithromyci ...... an sinonasal epithelial cells.

@en

P1476

Itraconazole and clarithromyci ...... an sinonasal epithelial cells.

@en

P2093

Allen Lam

http://www.w3.org/2001/XMLSchema#string

Amy Singleton

http://www.w3.org/2001/XMLSchema#string

Benjamin S Bleier

http://www.w3.org/2001/XMLSchema#string

John D Hoang

http://www.w3.org/2001/XMLSchema#string

Xue Han

http://www.w3.org/2001/XMLSchema#string

P2860

The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis.

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999

The role of itraconazole in recalcitrant fungal sinusitis.

Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis.

Regional expression of epithelial MDR1/P-glycoprotein in chronic rhinosinusitis with and without nasal polyposis.

Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment.

Medical therapy as the primary modality for the management of chronic rhinosinusitis.

P-glycoprotein is a marker of tissue eosinophilia and radiographic inflammation in chronic rhinosinusitis without nasal polyps.

Oral antibiotics and the management of chronic sinusitis: what do we know?

Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis.

P304

477-480

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ALR.21454

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275357364

http://www.w3.org/2001/XMLSchema#string

P698

25907295

http://www.w3.org/2001/XMLSchema#string

Itraconazole and clarithromycin inhibit P-glycoprotein activity in primary human sinonasal epithelial cells.

about

P2860

P2860

Itraconazole and clarithromycin inhibit P-glycoprotein activity in primary human sinonasal epithelial cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698